Form 4 for BIIB Biogen
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001127602-23-023824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-05 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $269.43 | -431 | 3,354 | -11% | -$116.1K |
| D | 2023-09-06 | 2023-09-01 | BIIB | Singhal Priya | Head of Development | F - Tax | $267.17 | -807 | 3,785 | -18% | -$215.6K |
| D | 2023-09-06 | 2023-09-01 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,668 | 4,592 | +57% | $0 |
| D | 2023-09-06 | 2023-09-01 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -1,668 | 3,337 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | S | D | 431 | $269.43 | 3,354.09 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | F | D | 807 | $267.17 | 3,785.09 | D | — | — | |
| 3 | Common | Common Stock | 2023-09-01 | M | A | 1,668 | $0.00 | 4,592.09 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2023-09-01 | M | D | 1,668 | $0.00 | 3,337 | D | $0.00 · — to 2025-09-01 | 1,668 Common Stock | (F1) This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date. |